Venetoclax Combination as Induction Therapy in AML and MDS | Blood Cancers Today
First-line induction therapy with CLIA-venetoclax achieved high rates of complete response and MRD negativity in patients with newly-diagnosed AML and MDS.
Related Articles
Home | Multiple Myeloma Hub
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
Welcome! You are invited to join a webinar: Post-ASH 2024 CML highlights webinar. After registering, you will receive a confirmation email about joining the webinar.
Join us to watch leading CML experts present summaries on the most significant abstracts from ASH 2024 followed by interactive panel discussions debating current clinical…
Early Findings on Ziftomenib With Chemotherapy in AML From KOMET-007 Trial | Blood Cancers Today
Ziftomenib plus standard cytarabine and daunorubicin chemotherapy was well tolerated with consistent safety and continued to show robust clinical activity in NPM1-mutated AML.
Loncastuximab Combination Shows Dramatic Activity in High-Risk, R/R Follicular Lymphoma | Blood Cancers Today
In patients with high-risk, relapsed or refractory follicular lymphoma,loncastuximab combined with rituximab is a potential as a new treatment option, phase 2 results show.
Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Alternating Venetoclax Regimens Strategy for Newly Diagnosed AML | Blood Cancers Today
Cladribine, low-dose cytarabine, and venetoclax alternating with azacitidine and venetoclax showed high responses and MRD negativity in patients with newly-diagnosed AML.
Clinical Experts Discuss Momelotinib for Myelofibrosis: Anemia Utility, Dosing, Safety | Blood Cancers Today
The panel moderated by Prithviraj Bose, MD, goes into detail on practical aspects of this agent’s use in the clinic.
VJOncology – The video journal of oncology
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the…
Can Immunotherapy Go the Distance in ES/LS Small-Cell Lung Cancer?
The FDA gave an accelerated OK to a BiTe therapy, but an IO-chemoRT combo was a non-starter
Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial
Baltimore Region: Due to the recent collapse of the Francis Scott Key Bridge, please anticipate delays when travelling to appointments. More information. Adding a personalized…
